Salomon & Ludwin’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.8K Sell
97
-977
-91% -$469K ﹤0.01% 538
2026
Q1
$528K Sell
1,074
-21
-2% -$11.4K 0.05% 113
2025
Q4
$669K Buy
1,095
+17
+2% +$9.61K 0.06% 103
2025
Q3
$586K Buy
1,078
+151
+16% +$70.3K 0.05% 105
2025
Q2
$397K Hold
927
0.04% 120
2025
Q1
$461K Hold
927
0.05% 108
2024
Q4
$482K Sell
927
-519
-36% -$285K 0.05% 102
2024
Q3
$894K Hold
1,446
0.09% 84
2024
Q2
$800K Sell
1,446
-104
-7% -$59.6K 0.09% 90
2024
Q1
$901K Buy
1,550
+82
+6% +$46K 0.08% 97
2023
Q4
$743K Hold
1,468
0.08% 96
2023
Q3
$743K Hold
1,468
0.08% 96
2023
Q2
$766K Hold
1,468
0.08% 90
2023
Q1
$846K Hold
1,468
0.1% 79
2022
Q4
$808K Sell
1,468
-12
-0.8% -$6.36K 0.1% 80
2022
Q3
$751K Buy
1,480
+547
+59% +$306K 0.11% 71
2022
Q2
$507K Buy
+933
New +$514K 0.08% 73
2019
Q2
Sell
-23
Closed -$6.33K 270
2019
Q1
$6K Buy
+23
New +$5.72K ﹤0.01% 183

Other funds holding TMO

Salomon & Ludwin's TMO Position: Q2 2026 in Review

Salomon & Ludwin reduced its Thermo Fisher Scientific (TMO) stake by 91% in Q2 2026, selling an estimated $469K and leaving 97 shares worth $49.8K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Salomon & Ludwin first reported a position in TMO in Q1 2019 and has held it in 18 quarters since. The position peaked at $901K in Q1 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Salomon & Ludwin held 97 shares of Thermo Fisher Scientific worth $49.8K as of Q2 2026.
  • Salomon & Ludwin sold 977 Thermo Fisher Scientific shares in Q2 2026, an estimated $469K.
  • Thermo Fisher Scientific made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #538 holding.
  • Salomon & Ludwin first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 18 quarters since.
  • Salomon & Ludwin's Thermo Fisher Scientific position peaked at $901K in Q1 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.